Results 81 to 90 of about 7,325 (186)

Cytokine Milieu Relevant to Atopic Dermatitis Enhances Epidermal Trypsin‐Like Serine Protease Activity, Which Is Pharmacologically Suppressed in Human Keratinocytes

The Journal of Dermatology, Volume 53, Issue 3, Page 532-534, March 2026.
Shiori Onishi, Yohei Yasutomi, Onon Tsedendorj, Shin Morizane   +3 more
wiley   +1 more source

Role of Desmoglein Autoantibody in the Diagnosis of Pemphigus Vulgaris: A Case Report

Acta Medica Indonesiana
Pemphigus vulgaris (PV) is a group of autoimmune diseases that cause abnormalities in the form of lesions or blisters on the skin and mucous membranes. It often presents diagnostic challenges due to its varied clinical manifestations. Accurate diagnosis
Diane Lukito Setiawan, Munawaroh Fitriah, Awalia Awalia   +2 more
doaj  

Desmoglein Versus Non-desmoglein Signaling in Pemphigus Acantholysis [PDF]

Journal of Biological Chemistry, 2007
Alex I. Chernyavsky, Juan Arredondo, Yasuo Kitajima, Miki Sato-Nagai, Sergei A. Grando   +4 more
openaire   +1 more source

Comparison of BIOCHIP Mosaic Based Indirect Immunofluorescence and Oral Direct Immunofluorescence in Patients with Oral Mucosal Pemphigus

Indian Dermatology Online Journal
Background: Oral mucosal lesions in pemphigus vulgaris may precede cutaneous lesions and can cause diagnostic confusion. Diagnosis can be made by histopathology, direct immunofluorescence (DIF), and indirect immunofluorescence (IIF).
Amrithaa Muralitharan, Reena Rai, Sakthisankari Shanmugasundaram   +2 more
doaj   +1 more source

Rilzabrutinib-induced transition from pemphigus vulgaris to pemphigus foliaceous: case report and review of the literature

Dermatology Reports
The discovery of the role of Bruton’s Tyrosine Kinase (BTK) in inflammation and autoimmunity has recently led to the development of BTK inhibitors for the treatment of autoimmune diseases, including pemphigus vulgaris.
Christian Ciolfi, Jacopo Tartaglia, Francesca Pampaloni, Laura Fagotto, Andrea Sechi, Mauro Alaibac   +5 more
doaj  

Desmoglein autoimmunity in the pathogenesis of pemphigus

Autoimmunity, 2006
The most characteristic feature of pemphigus is a loss of cohesion between keratinocytes, resulting in formation of blisters and erosions on the mucosal membranes and the skin. Identification of circulating antibodies which bind to desmogleins (Dsg), transmembrane proteins involved in assembly of the desmosomes, led to the immediate realization that ...
openaire   +2 more sources

Rituximab in the Management of Autoimmune Bullous Diseases: A Treatment-Resistant Case Series from a Single Central European Referral Center

Medicina
Background and Objectives: Rituximab (RTX) has been the predominant treatment for autoimmune bullous diseases (AIBDs). The objective of this research was to assess the advantages and safety characteristics of RTX treatment in individuals with AIBD.
Maciej Marek Spałek, Magdalena Jałowska, Monika Bowszyc-Dmochowska, Marian Dmochowski   +3 more
doaj   +1 more source

Desmoglein-3 [PDF]

, 2020
openaire   +1 more source

Pemphigus foliaceus presenting with violaceous, painful nodules and an aberrant auto-antibody expression in a Latino patient

JAAD Case Reports, 2021
Jeffrey N. Li, BS, BBA, Parth Patel, MD, Cristian Gonzalez, MD, Travis Vandergriff, MD, Heather Goff, MD   +4 more
doaj   +1 more source

Desmoglein-Autoantikörper [PDF]

, 2019
openaire   +1 more source